245 related articles for article (PubMed ID: 31968140)
21. Analysis of NQO1 polymorphisms and p53 protein expression in patients with hepatocellular carcinoma.
Chiu MM; Ko YJ; Tsou AP; Chau GY; Chau YP
Histol Histopathol; 2009 Oct; 24(10):1223-32. PubMed ID: 19688691
[TBL] [Abstract][Full Text] [Related]
22. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma.
Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K
Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322
[TBL] [Abstract][Full Text] [Related]
23. No association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatocellular carcinoma development in Turkish subjects.
Akkiz H; Bayram S; Bekar A; Akgöllü E; Ülger Y; Kaya BY; Sandikçi M; Özdil B
Asian Pac J Cancer Prev; 2010; 11(4):1051-8. PubMed ID: 21133623
[TBL] [Abstract][Full Text] [Related]
24. Prognostic implication of NQO1 overexpression in hepatocellular carcinoma.
Lin L; Sun J; Tan Y; Li Z; Kong F; Shen Y; Liu C; Chen L
Hum Pathol; 2017 Nov; 69():31-37. PubMed ID: 28964792
[TBL] [Abstract][Full Text] [Related]
25. Dual-negative expression of Nrf2 and NQO1 predicts superior outcomes in patients with non-small cell lung cancer.
Tong YH; Zhang B; Yan YY; Fan Y; Yu JW; Kong SS; Zhang D; Fang L; Su D; Lin NM
Oncotarget; 2017 Jul; 8(28):45750-45758. PubMed ID: 28501854
[TBL] [Abstract][Full Text] [Related]
26. Nrf2 is a potential prognostic marker and promotes proliferation and invasion in human hepatocellular carcinoma.
Zhang M; Zhang C; Zhang L; Yang Q; Zhou S; Wen Q; Wang J
BMC Cancer; 2015 Jul; 15():531. PubMed ID: 26194347
[TBL] [Abstract][Full Text] [Related]
27. Protection of NAD(P)H:quinone oxidoreductase 1 against renal ischemia/reperfusion injury in mice.
Gang GT; Hwang JH; Kim YH; Noh JR; Kim KS; Jeong JY; Choi DE; Lee KW; Jung JY; Shong M; Lee CH
Free Radic Biol Med; 2014 Feb; 67():139-49. PubMed ID: 24189322
[TBL] [Abstract][Full Text] [Related]
28. Synergistic enhancement of antitumor effect of β-Lapachone by photodynamic induction of quinone oxidoreductase (NQO1).
Lamberti MJ; Vittar NB; da Silva Fde C; Ferreira VF; Rivarola VA
Phytomedicine; 2013 Aug; 20(11):1007-12. PubMed ID: 23746950
[TBL] [Abstract][Full Text] [Related]
29. Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species.
Lee D; Zhang MS; Tsang FH; Bao MH; Xu IM; Lai RK; Chiu DK; Tse AP; Law CT; Chan CY; Yuen VW; Chui NN; Ng IO; Wong CM; Wong CC
Hepatology; 2021 Aug; 74(2):776-796. PubMed ID: 33619771
[TBL] [Abstract][Full Text] [Related]
30. Nuclear factor erythroid 2-related factor 2 and β-Catenin Coactivation in Hepatocellular Cancer: Biological and Therapeutic Implications.
Tao J; Krutsenko Y; Moghe A; Singh S; Poddar M; Bell A; Oertel M; Singhi AD; Geller D; Chen X; Lujambio A; Liu S; Monga SP
Hepatology; 2021 Aug; 74(2):741-759. PubMed ID: 33529367
[TBL] [Abstract][Full Text] [Related]
31. ZNF32 induces anoikis resistance through maintaining redox homeostasis and activating Src/FAK signaling in hepatocellular carcinoma.
Li K; Zhao G; Ao J; Gong D; Zhang J; Chen Y; Li J; Huang L; Xiang R; Hu J; Lin P; Wei Y
Cancer Lett; 2019 Feb; 442():271-278. PubMed ID: 30439540
[TBL] [Abstract][Full Text] [Related]
32. LMO3 promotes hepatocellular carcinoma invasion, metastasis and anoikis inhibition by directly interacting with LATS1 and suppressing Hippo signaling.
Cheng Y; Hou T; Ping J; Chen T; Yin B
J Exp Clin Cancer Res; 2018 Sep; 37(1):228. PubMed ID: 30219064
[TBL] [Abstract][Full Text] [Related]
33. Impact of Nrf2 on tumour growth and drug sensitivity in oncogenic K-ras-transformed cells in vitro and in vivo.
Shao J; Glorieux C; Liao J; Chen P; Lu W; Liang Z; Wen S; Hu Y; Huang P
Free Radic Res; 2018 Jun; 52(6):661-671. PubMed ID: 29621903
[TBL] [Abstract][Full Text] [Related]
34. NRF2 DLG Domain Mutations Identified in Japanese Liver Cancer Patients Affect the Transcriptional Activity in HCC Cell Lines.
Haque E; Śmiech M; Łuczyńska K; Bouchard MF; Viger R; Kono H; Pierzchała M; Taniguchi H
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069882
[TBL] [Abstract][Full Text] [Related]
35. MCUR1 facilitates epithelial-mesenchymal transition and metastasis via the mitochondrial calcium dependent ROS/Nrf2/Notch pathway in hepatocellular carcinoma.
Jin M; Wang J; Ji X; Cao H; Zhu J; Chen Y; Yang J; Zhao Z; Ren T; Xing J
J Exp Clin Cancer Res; 2019 Mar; 38(1):136. PubMed ID: 30909929
[TBL] [Abstract][Full Text] [Related]
36. Spatial Analysis of NQO1 in Non-Small Cell Lung Cancer Shows Its Expression Is Independent of NRF1 and NRF2 in the Tumor Microenvironment.
Kaghazchi B; Um IH; Elshani M; Read OJ; Harrison DJ
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36359002
[TBL] [Abstract][Full Text] [Related]
37. Astrocyte elevated gene 1 (AEG-1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinoma.
Zhu HD; Liu L; Deng H; Li ZB; Sheng JQ; He XX; Tian DA; Li PY
J Cell Physiol; 2020 Jun; 235(6):5084-5095. PubMed ID: 31691973
[TBL] [Abstract][Full Text] [Related]
38. Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.
Feng MX; Ma MZ; Fu Y; Li J; Wang T; Xue F; Zhang JJ; Qin WX; Gu JR; Zhang ZG; Xia Q
Mol Cancer; 2014 Oct; 13():226. PubMed ID: 25273699
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II induces oxidative stress and upregulates neuroprotective signaling from the NRF2 and KLF9 pathway in dopaminergic cells.
Parga JA; Rodriguez-Perez AI; Garcia-Garrote M; Rodriguez-Pallares J; Labandeira-Garcia JL
Free Radic Biol Med; 2018 Dec; 129():394-406. PubMed ID: 30315936
[TBL] [Abstract][Full Text] [Related]
40. The Expression and Prognostic Value of Cancer Stem Cell Markers, NRF2, and Its Target Genes in TAE/TACE-Treated Hepatocellular Carcinoma.
Tseeleesuren D; Hsiao HH; Kant R; Huang YC; Tu HP; Lai CC; Huang SF; Yen CH
Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208536
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
